Daiichi Earns Win Against Mylan Over Benicar Patent
A federal judge has ruled that Mylan Pharmaceuticals Inc. infringed Daiichi Sankyo Co. Ltd.'s patent for the active ingredient in Benicar when Mylan tried to market a generic version of the...To view the full article, register now.
Already a subscriber? Click here to view full article